Lenacapavir: breakthrough HIV prevention shot twice yearly, but for everyone?

Lenacapavir, a new injectable drug administered twice a year to prevent HIV infection, is hailed as a breakthrough in prevention. Experts warn, however, that access to the drug will be unequal — not everyone who needs it will be able to use it. Questions of availability and cost remain a key barrier.